OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation
Allison M. Garrison, Jennifer M. Parrott, Arnulfo Tuñon, et al.
Psychoneuroendocrinology (2018) Vol. 94, pp. 1-10
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

The kynurenine pathway: a finger in every pie
Jonathan Savitz
Molecular Psychiatry (2019) Vol. 25, Iss. 1, pp. 131-147
Open Access | Times Cited: 530

Tryptophan Metabolism and Gut-Brain Homeostasis
William Roth, Kimia Zadeh, Rushi Vekariya, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2973-2973
Open Access | Times Cited: 307

Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Haixia Wang, Yi He, Zuoli Sun, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 283

Tryptophan Metabolism as a Pharmacological Target
Morgane Modoux, Nathalie Rolhion, Sridhar Mani, et al.
Trends in Pharmacological Sciences (2020) Vol. 42, Iss. 1, pp. 60-73
Open Access | Times Cited: 223

Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders
Adrian Mor, Anna Tankiewicz‐Kwedlo, Anna Krupa, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1603-1603
Open Access | Times Cited: 123

Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
Mustafa N. Mithaiwala, Danielle Santana‐Coelho, Grace A. Porter, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1548-1548
Open Access | Times Cited: 117

Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease
Grzegorz A. Czapski, Joanna B. Strosznajder
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11677-11677
Open Access | Times Cited: 106

Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process
Antero Salminen
Ageing Research Reviews (2022) Vol. 75, pp. 101573-101573
Open Access | Times Cited: 87

Stress induced microglial activation contributes to depression
Bingjin Li, Wei Yang, Tongtong Ge, et al.
Pharmacological Research (2022) Vol. 179, pp. 106145-106145
Closed Access | Times Cited: 80

Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation
Jingru Liu, Hua Miao, Deqiang Deng, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 3, pp. 909-922
Closed Access | Times Cited: 136

Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations
Ather Muneer
Clinical Psychopharmacology and Neuroscience (2020) Vol. 18, Iss. 4, pp. 507-526
Open Access | Times Cited: 105

Host–microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling
Ning Ma, Ting He, L. J. Johnston, et al.
Gut Microbes (2020) Vol. 11, Iss. 5, pp. 1203-1219
Open Access | Times Cited: 94

The emerging tale of microglia in psychiatric disorders
Reza Rahimian, Marina Wakid, Liam Anuj O’Leary, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 1-29
Closed Access | Times Cited: 80

Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 8

Immunomodulatory mechanisms driving tumor escape in Glioblastoma: the central role of IDO and tryptophan metabolism in local and systemic immunotolerance
Filippo Gagliardi, Pierfrancesco De Domenico, Silvia Snider, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104657-104657
Closed Access | Times Cited: 1

The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders
Maryam Assem, Mathilde Lando, Maria Grissi, et al.
Toxins (2018) Vol. 10, Iss. 7, pp. 303-303
Open Access | Times Cited: 81

Cellular mechanisms and molecular signaling pathways in stress-induced anxiety, depression, and blood–brain barrier inflammation and leakage
Menizibeya O. Welcome
Inflammopharmacology (2020) Vol. 28, Iss. 3, pp. 643-665
Closed Access | Times Cited: 56

Inflammatory Process and Immune System in Major Depressive Disorder
Norma Angélica Labra Ruiz, S S Daniel, Norma Osnaya Brizuela, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 1, pp. 46-53
Open Access | Times Cited: 55

Oxidative Dysregulation in Early Life Stress and Posttraumatic Stress Disorder: A Comprehensive Review
Evangelos Karanikas, Nikolaos P. Daskalakis, Agorastos Agorastos
Brain Sciences (2021) Vol. 11, Iss. 6, pp. 723-723
Open Access | Times Cited: 53

Kynurenine Pathway in Chronic Kidney Disease: What’s Old, What’s New, and What’s Next?
Adrian Mor, Bartłomiej Kałaska, Dariusz Pawlak
International Journal of Tryptophan Research (2020) Vol. 13
Open Access | Times Cited: 51

Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression
Ferenc Zádor, Sâmia R.L. Joca, Gábor Nagy-Grócz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5903-5903
Open Access | Times Cited: 42

DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota
Liping Zhao, Jian Wu, Wei Quan, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 18

Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine
Fabiola Stolfi, Hugo Abreu, Riccardo Sinella, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6

Microglia as therapeutic target in central nervous system disorders
Oluwaseun Fatoba, Takahide Itokazu, Toshihide Yamashita
Journal of Pharmacological Sciences (2020) Vol. 144, Iss. 3, pp. 102-118
Open Access | Times Cited: 44

Page 1 - Next Page

Scroll to top